Nocturnal enuresis
renal · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Involuntary bedwetting in a child aged 5 or over. Primary mono-symptomatic enuresis (never dry, no daytime symptoms) is common and usually resolves; assessment separates it from secondary enuresis and daytime (non-mono-symptomatic) causes.
Red flags
- Secondary enuresis with weight loss/polydipsia (diabetes)
- Daytime wetting, straining, or poor urinary stream (bladder/neurological cause)
- Recurrent UTIs or abnormal lower limb neurology/spinal signs
- Severe behavioural or safeguarding concern
Assessment
Differential diagnosis
- Primary mono-symptomatic nocturnal enuresis (commonest)
- Non-mono-symptomatic enuresis with daytime bladder dysfunction
- Secondary enuresis (UTI, diabetes, constipation, psychological stress)
- Diabetes mellitus or insipidus (polyuria)
- Constipation reducing bladder capacity
- Obstructive sleep apnoea
- Neurological bladder (rare; look for spinal signs)
Investigations
- History distinguishing primary vs secondary and daytime symptoms
- Fluid intake, voiding and wetting diary
- Urinalysis for infection and glucose
- Assess for and treat constipation
- No routine imaging unless daytime symptoms or recurrent UTI/neurological signs
- Consider assessment for OSA if snoring
Management
- Confirm age over 5 and classify as primary/secondary and mono- or non-mono-symptomatic
- Treat constipation and any UTI first as these commonly drive wetting
- Exclude diabetes with urinalysis if polyuria/polydipsia
- Give simple advice: regular daytime fluids, reduce evening fluids/caffeine, void before bed
- Address daytime bladder dysfunction before treating night-time wetting
- Offer an enuresis alarm as first-line for motivated families seeking long-term cure
- Offer desmopressin where rapid/short-term dryness needed or alarm unsuitable
- Combine alarm and desmopressin or refer if refractory
- Provide reassurance, avoid punishment, and arrange follow-up
Drugs & doses
Desmopressin 120-240 microgram sublingual (melt) or 200-400 microgram tablet PO at bedtime
Oxybutynin PO (anticholinergic) for coexisting overactive bladder, specialist-guided
Treat constipation with macrogol as per constipation protocol
Fluid restriction around desmopressin dosing to avoid hyponatraemia
Disposition
Primary care/community enuresis clinic; refer to paediatrics for daytime symptoms, treatment-resistant cases, or red flags.
Complications & pitfalls
- Psychological distress, low self-esteem and social restriction
- Hyponatraemia from desmopressin if fluids not restricted
- Relapse after stopping treatment
- Missed underlying diabetes or constipation
Exam pearls
- Treat constipation and daytime symptoms before tackling night-time wetting
- An alarm offers the best chance of lasting cure but needs motivation and time
- Desmopressin gives rapid dryness (e.g. for sleepovers) but relapse is common on stopping
- Restrict fluids around desmopressin to prevent hyponatraemia; never punish the child
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.